Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Classifica tra le azioni #27810
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Prezzo delle azioni
$0.0492516
Capitalizzazione di mercato
$30.41M
Variazione (1 giorno)
1.32%
Variazione (1 anno)
-91.28%
Paese
CN
Scambia Immunotech Biopharm Ltd (6978)

Categoria

Cronologia dei frazionamenti azionari per Immunotech Biopharm Ltd (6978)
L’azione Immunotech Biopharm Ltd (simbolo: 6978) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 20, 2026.
Una quota di 6978 acquistata prima di Aug 20, 2026 equivale oggi a 0 quote di 6978.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH